Acquiring Company
RAMM PHARMA
Acquired Company
CONTECHS
Toronto
BasildonManufacturingBiotechnologyPharmaceuticalCannabisDescription
RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to announce that today it has acquired all of the issued and outstanding shares of HemPoland S.p.a. Z.o.o. (“HemPoland”) from The Green Organic Dutchman Holdings Ltd. (CSE: TGOD) for cash consideration of C$1.2 million.
Quick answer
RAMM PHARMA is acquiring CONTECHS, announced September 6, 2022. RAMM PHARMA is based in Toronto, Ontario, Canada.
- How much did RAMM PHARMA pay for CONTECHS?
- The deal value was not disclosed.
- What does RAMM PHARMA do?
- RAMM PHARMA Corp is a company listed on the stock market.
- Where are RAMM PHARMA and CONTECHS based?
- RAMM PHARMA is based in Toronto, Ontario, Canada. CONTECHS is based in Basildon, England, United Kingdom.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Cannabis
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Catalent To Acquire Metrics Contract Services For $475 Million To Expand High-Potent Capabilities And Oral Development And Manufacturing Capacity, $475M (August 9, 2022)
- Lilly To Acquire Akouos To Discover And Develop Treatments For Hearing Loss (October 18, 2022)
- Collagen Matrix Acquires Polyganics (October 5, 2022)
- Sumitovant Biopharma And Sumitomo Pharma Announce Offer To Acquire Outstanding Shares Of Myovant Sciences (October 2, 2022)
- Bristol Myers Squibb Completes Acquisition Of Turning Point Therapeutics, Expanding Precision Oncology Portfolio (August 17, 2022)
- Bristol Myers Squibb And Turning Point Therapeutics Announce Expiration Of Hsr Act Waiting Period And Clearance From Federal Cartel Office Of Germany Related To Pending Acquisition Of Turning Point Therapeutics (August 16, 2022)
Who to call at RAMM PHARMA, and when
When RAMM PHARMA changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day RAMM PHARMA raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RAMM PHARMA, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RAMM PHARMA. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RAMM PHARMA makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired CONTECHS?
CONTECHS was acquired by RAMM PHARMA, based in Toronto. The deal was reported on September 6, 2022. RAMM PHARMA Corp is a company listed on the stock market. It was the target of an acquisition involving a significant number of its common shares. The company is engaged in the pharmaceutical sector. RAMM PHARMA is privately held and operates in Manufacturing.
When did RAMM PHARMA acquire CONTECHS?
RAMM PHARMA's acquisition of CONTECHS was reported on September 6, 2022. RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to announce that today it has acquired all of the issued and outstanding shares of HemPoland S.p.a. Z.o.o. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does CONTECHS do?
Contechs is a strategic partner to the automotive industry, providing innovative design and engineering services to global OEMs, from concept to production. It is privately held, and is based in Basildon.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.